VelsafeVelsafe

Workplace Safety Guides, Insights & Training

Velocity Safe Blog
  • Sign in /
  • join
  • Home
  • Insights
  • Guides
  • Practice Tests
  • Tips
  • Worker Safety
  • Situational
  • OSHA Tools
  • Law

Home » Pharmaceutical GMPs » Page 3

Pharmaceutical GMPs

EU GMP Annex 11 2025 draft statistics showing expansion from 5 to 19 pages with 7 new sections covering cybersecurity risk assessment, cloud and SaaS scope, AI systems under companion Annex 22, ALCOA plus plus data integrity framework, and senior management accountability with October 2025 consultation deadline
June 16, 2026
by VelSafe Editorial Team Insights

EU GMP Annex 11 2025 Draft: 30+ Data Points on What Changes and Why It Matters

Read More
Compliance officer reviewing FDA Warning Letter response
September 2, 2025
by VelSafe Editorial Team Situational

FDA Warning Letter Mistakes to Avoid

How to protect compliance, avoid escalation, and respond with confidence ⏱️ 8 min read  |  Updated: September 2025 Table of Contents The FDA Compliance Context Why Effective Res

Read More
DEA Compliance Safety Protocols for Manufacturing Staff Handling Controlled Substances (USA)
August 3, 2025
by VelSafe Editorial Team Worker Safety

DEA Compliance Safety Protocols for Manufacturing Staff Handling Controlled Substances (USA)

Manufacturing controlled substances in the U.S. is a high-responsibility job. These materials can be harmful if misused, so strict safety protocols are required. The Drug Enforcement Administration (DEA) has clear rules to protect the public, prevent

Read More
CAPA in crisis featured image showing a female pharmaceutical quality manager reviewing a nonconformance report at a stainless steel workbench with temperature-alert refrigeration units in the background, and a CAPA response sequence step card overlay on the right panel.
July 30, 2025
by VelSafe Editorial Team Situational

CAPA in Crisis: Managing Nonconformance After Natural Disasters or Power Outages

SITUATIONAL: CAPA and Crisis Nonconformance CAPA in Crisis: Managing Nonconformance After Natural Disasters or Power Outages When a power outage or natural disaster disrupts a regulated facility, the compliance obligation does not pause with

Read More
Annual Product Review guide for pharmaceutical QA teams covering 9 steps from data collection and trend analysis to defensible conclusions, CAPA tracking and FDA inspection readiness under 21 CFR 211.180
July 25, 2025
by VelSafe Editorial Team Guides

How to Conduct an Annual Product Review (APR): A Step-by-Step Guide for Pharma QA Teams

Read More
Pharmaceutical complaint investigation backlog statistics infographic showing 210-256 day average investigation timelines against a 30-day target, 105 FDA quality warning letters in FY2024 (a five-year high), 34% OOS investigation failure rate in 2025 warning letters, and 695 total FDA enforcement letters in 2025, based on FDA CDER OPQ FY2024 quality report and qBench analysis.
July 24, 2025
by VelSafe Editorial Team Insights

Pharma Complaint Investigation Backlogs: 40+ Statistics Through 2025-26

Read More
Common Mistakes in Cleaning Validation Sampling and How to Avoid
July 22, 2025
by VelSafe Editorial Team Guides

Common Mistakes in Cleaning Validation Sampling and How to Avoid Them

Cleaning validation is a key part of pharmaceutical and medical device manufacturing. It proves that the equipment is clean enough before it is used again. One important step in cleaning validation is sampling, checking equipment for leftover product

Read More
Who Is Legally Accountable in a Change Control Failure Quality, Operations, or Management
July 20, 2025
by VelSafe Editorial Team Law

Who Is Legally Accountable in a Change Control Failure? Quality, Operations, or Management?

In pharmaceutical and biotech manufacturing, changes to processes, equipment, or materials must be handled carefully. That’s why change control is a critical part of any company’s current Good Manufacturing Practice (cGMP) system. But when change con

Read More
Pharmaceutical Quality Risks During Seasonal Surge Production
July 20, 2025
by VelSafe Editorial Team Situational

Pharmaceutical Quality Risks During Seasonal Surge Production

Every year, certain times bring a sudden rise in demand for specific medicines. Cold and flu season, allergy season, and even pandemic waves can lead to pressure on pharmaceutical companies to increase production quickly. While this may help meet pub

Read More
FDA Regulation of Biotechnology-Derived Products What You Must Know to Stay Compliant
July 19, 2025
by VelSafe Editorial Team Law

FDA Regulation of Biotechnology-Derived Products: What You Must Know to Stay Compliant

Biotechnology-derived products (BDPs), such as monoclonal antibodies, gene therapies, and recombinant proteins, are a growing part of modern medicine. These products hold great promise for treating diseases, but they also come with strict regulatory

Read More
  • First
  • Previous
  • 1
  • 2
  • 3
  • 4
  • Next
  • Last

Subscribe Now

VelSafe Subscribe
VelsafeVelsafe

Workplace Safety Guides, Insights & Training

Linkedin Twitter Instagram
Category
  • Insights
  • Guides
  • TIPS
  • LAW
  • Practice Tests
  • SITUATIONAL
Info
  • About Us
  • Get Featured
  • Newsletter
  • Contact Us
Popular Posts
Medicare Advantage provider compliance law 42 CFR Part 422 showing network adequacy credentialing prompt payment participation rules and anti-discrimination requirements
September 5, 2026

Medicare Advantage Provider Compliance: The Law

Medicare Advantage Part C and Part D grievances law compliance binders and grievance process checklist
September 4, 2026

Medicare Advantage Grievances: Part C and…

Newsletter

Send us a newsletter to get update


    © 2026 . All rights reserved.
    Shopping Basket